nz-4

Isothiafludine (NZ-4) is an orally active anti-HBV compound that acts by blocking the encapsulation of pre-genomic RNA (pgRNA) and interfering with nucleosome capsid assembly, and is used in the study of HBV infections.

Inz-4 is a fungal-selective inhibitor of mitochondrial cytochrome bc1.

QNZ46 is a non-competitive antagonist of NMDA receptors, selectively targeting NR2C/NR2D subunits.

(Nz)-n-(6-fluoro-2,3-dihydrothiochromen-4-ylidene)hydroxylamine ,with CAS No. 50596-11-7, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. (Nz)-n-(6-fluoro-2,3-dihydrothiochromen-4-ylidene)hydroxylamine provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

NZ-97 is an inhibitor of dipeptidyl peptidase 4 (DPP4) with an IC50 of 18 nM. It exhibits low initial plasma exposure with a Cmax of 0.13 µM and is eliminated within 8 hours. NZ-97 can ameliorate lipopolysaccharides-induced lung injury and bleomycin-induced pulmonary fibrosis in mouse models.